
Taro Pharmaceutical Industries Ltd. TARO
Annual report 2022
added 07-25-2022
Taro Pharmaceutical Industries Ltd. Total Inventories 2011-2026 | TARO
Annual Total Inventories Taro Pharmaceutical Industries Ltd.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210 M | 180 M | 153 M | 148 M | 145 M | 141 M | 139 M | 120 M | 118 M | 110 M | 110 M | 107 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 210 M | 107 M | 140 M |
Quarterly Total Inventories Taro Pharmaceutical Industries Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 180 M | - | - | - | 153 M | - | - | - | 148 M | - | - | - | 145 M | - | - | - | 141 M | - | - | - | 139 M | - | - | - | 120 M | - | - | - | 118 M | - | - | - | 110 M | - | - | - | 110 M | 107 M | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 180 M | 107 M | 134 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
Alnylam Pharmaceuticals
ALNY
|
82.7 M | $ 320.13 | -3.98 % | $ 41.9 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
177 M | $ 21.81 | 0.6 % | $ 1.02 B | ||
|
Akebia Therapeutics
AKBA
|
15.6 M | $ 1.35 | -12.9 % | $ 347 M | ||
|
Aquestive Therapeutics
AQST
|
6.17 M | $ 4.26 | 0.47 % | $ 456 M | ||
|
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 24.19 | -1.59 % | $ 3.08 B | ||
|
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.61 | 8.05 % | $ 428 M | ||
|
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B | ||
|
Caladrius Biosciences
CLBS
|
1.27 M | - | -16.75 % | $ 25.8 M | ||
|
bluebird bio
BLUE
|
22.9 M | - | - | $ 546 M |